Efficacy and safety of using non-steroidal anti-inflammatory drugs in ophthalmology

Article Sidebar

PDF (Język Polski)


Published: Jun 30, 2019
DOI: https://doi.org/10.24292/01.OT.300619.03
Keywords:
non-steroidal anti-inflammatory drugs, prostaglandins, anti-inflammatory topical treatment, drug pharmacokinetics

Main Article Content

Jarosław Woroń
1. Zakład Farmakologii Klinicznej, Katedra Farmakologii, Wydział Lekarski, Uniwersytet Jagielloński – Collegium Medicum. 2. Szpital Uniwersytecki w Krakowie

Abstract

Non-steroidal anti-inflammatory drugs (NSAIDs) are one of the most commonly used groups of drugs in ophthalmic pharmacotherapy. Numerous indications for the use of this group of drugs as well as the role of prostaglandins in the pathomechanism of the formation of eye diseases make this group of drugs still developing. The ophthalmologist has several NSAIDs available, which differ mainly in pharmacokinetic parameters. The choice of NSAIDs should be individualized to select the most effective and safest drug for a particular patient

Downloads

Download data is not yet available.

Article Details

How to Cite
1.
Woroń J. Efficacy and safety of using non-steroidal anti-inflammatory drugs in ophthalmology. Ophthatherapy [Internet]. 2019Jun.30 [cited 2024Nov.21];6(2):80-4. Available from: https://journalsmededu.pl/index.php/ophthatherapy/article/view/936
Issue
Vol 6 No 2 (2019)
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright: © Medical Education sp. z o.o. License allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)

References

1. Lanas A (ed). NSAID and Aspirin, Recent Advances and Implications for Clinical Management. Springer, Switzerland 2016.
2. Shear NH. Litt’s Drug Eruptions & Reactions Manual. 25th ed. CRC Press, Boca Raton 2019.
3. Kim SJ, Flach AJ, Jampol LM. Nonsteroidal anti-inflammatory drugs in ophthalmology. Surv Ophthalmol. 2010; 55: 108-33.
4. Jones B, Neville MW. Nepafenac: an ophthalmic nonsteroidal antiinflammatory drug for pain after cataract surgery. Ann Pharmacother. 2013; 47: 892-6.
5. Sahoo S, Baruna A, Myint KT et al. Topical non-steroidal anti-inflammatory agents for diabetic cystoid macular oedema (review). Cochrane Library. 2015; 2: 1-17.
6. Chisholm-Burns MA, Schwinghammer TL Malone PM et al. Pharmacotherapy. Principles & Practice, McGraw-Hill Education, New York 2019.
7. Rosenthal LD, Burchum JR. Pharmacotherapeutics for Advances Practice Providers. Elsevier, St Louis 2018.
8. DiPiro JT, Talbert LR, Yee GC et al. Pharmacotherapy, a Pathophysiologic Approach. McGraw-Hill Education, New York 2017.
9. Wirfs MJ. Prescribing Drug Therapy. Springer Publishing Company, New York 2019.
10. Ray DS (ed). Side Effects of Drugs Annual 40. Elsevier, Amsterdam 2018.